ArticleLeukemia2019

Commentary on "Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma" by Giovanni Barosi and Robert Peter Gale.

Sarah A Holstein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.